|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cho Y, Jung GH, Chung SH, Kim JY, Choi Y
and Kim JD: Long-term survivals of stage IIb osteosarcoma: A
20-year experience in a single institution. Clin Orthop Surg.
3:48–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bramer JA, van Linge JH, Grimer RJ and
Scholten RJ: Prognostic factors in localized extremity
osteosarcoma: A systematic review. Eur J Surg Oncol. 35:1030–1036.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pierz KA, Womer RB and Dormans JP:
Pediatric bone tumors: Osteosarcoma ewing's sarcoma and
chondrosarcoma associated with multiple hereditary
osteochondromatosis. J Pediatr Orthop. 21:412–418. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poletajew S, Fus L and Wasiutynski A:
Current concepts on pathogenesis and biology of metastatic
osteosarcoma tumors. Ortop Traumatol Rehabil. 13:537–545. 2011.(In
English, Polish). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J: Control of protein synthesis and
mRNA degradation by microRNAs. Curr Opin Cell Biol. 20:214–221.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carrington JC and Ambros V: Role of
microRNAs in plant and animal development. Science. 301:336–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan X, Fan S, Wu W and Zhang Y:
MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting
IGF-1. Bone Res. 3:150332015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao G, Dong L, Shi H, Li H, Lu X, Guo X
and Wang J: MicroRNA-1207-5p inhibits hepatocellular carcinoma cell
growth and invasion through the fatty acid synthase-mediated
Akt/mTOR signalling pathway. Oncol Rep. 36:1709–1716. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu D, Niu X, Pan H, Zhou Y, Qu P and Zhou
J: MicroRNA-335 is downregulated in bladder cancer and inhibits
cell growth, migration and invasion via targeting ROCK1. Mol Med
Rep. 13:4379–4385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu Y, Zhao Y, Sun XH, Ge J, Zhang B, Wang
X and Cao XC: Down-regulation of miR-129-5p via the Twist1-Snail
feedback loop stimulates the epithelial-mesenchymal transition and
is associated with poor prognosis in breast cancer. Oncotarget.
6:34423–34436. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang Z, Wang H, Li Y, Hou Z, Ma N, Chen
W, Zong Z and Chen S: miR-129-5p is down-regulated and involved in
migration and invasion of gastric cancer cells by targeting
interleukin-8. Neoplasma. 63:673–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Wang H, Ke H and Ni S: miR-129
regulates MMP9 to control metastasis of non-small cell lung cancer.
Tumour Biol. 36:5785–5790. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duan L, Hao X, Liu Z, Zhang Y and Zhang G:
miR-129-5p is down-regulated and involved in the growth, apoptosis
and migration of medullary thyroid carcinoma cells through
targeting RET. FEBS Lett. 588:1644–1651. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tan G, Cao X, Dai Q, Zhang B, Huang J,
Xiong S, Zhang Yy, Chen W, Yang J and Li H: A novel role for
microRNA-129-5p in inhibiting ovarian cancer cell proliferation and
survival via direct suppression of transcriptional co-activators
YAP and TAZ. Oncotarget. 6:8676–8686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karaayvaz M, Zhai H and Ju J: miR-129
promotes apoptosis and enhances chemosensitivity to 5-fluorouracil
in colorectal cancer. Cell Death Dis. 4:e6592013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma N, Chen F, Shen SL, Chen W, Chen LZ, Su
Q, Zhang LJ, Bi J, Zeng WT, Li W, et al: MicroRNA-129-5p inhibits
hepatocellular carcinoma cell metastasis and invasion via targeting
ETS1. Biochem Biophys Res Commun. 461:618–623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhai J, Qu S, Li X, Zhong J, Chen X, Qu Z
and Wu D: miR-129 suppresses tumor cell growth and invasion by
targeting PAK5 in hepatocellular carcinoma. Biochem Biophys Res
Commun. 464:161–167. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang QY, Tang J, Zhou CX and Zhao Q: The
down-regulation of miR-129 in breast cancer and its effect on
breast cancer migration and motility. Sheng Li Xue Bao. 64:403–411.
2012.(In Chinese). PubMed/NCBI
|
|
30
|
Luo J, Chen J and He L: mir-129-5p
Attenuates Irradiation-Induced Autophagy and Decreases
Radioresistance of Breast Cancer Cells by Targeting HMGB1. Med Sci
Monit. 21:4122–4129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang C, Zhang S, Zhang Z, He J, Xu Y and
Liu S: ROCK has a crucial role in regulating prostate tumor growth
through interaction with c-Myc. Oncogene. 33:5582–5591. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rossman KL, Der CJ and Sondek J: GEF means
go: Turning on RHO GTPases with guanine nucleotide-exchange
factors. Nat Rev Mol Cell Biol. 6:167–180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Patel RA, Forinash KD, Pireddu R, Sun Y,
Sun N, Martin MP, Schönbrunn E, Lawrence NJ and Sebti SM: RKI-1447
is a potent inhibitor of the Rho-associated ROCK kinases with
anti-invasive and antitumor activities in breast cancer. Cancer
Res. 72:5025–5034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y, Zhao W and Fu Q: miR-335
suppresses migration and invasion by targeting ROCK1 in
osteosarcoma cells. Mol Cell Biochem. 384:105–111. 2013. View Article : Google Scholar : PubMed/NCBI
|
